Oncology Research

In addition to being an active member of COG, the Children’s Oncology Group, which develops and maintains nationally recognized state-of-the-art research studies for the array of pediatric oncology diseases, we are also active participants in sponsored pharmaceutical trials.

Our current efforts include:

• prevention of tumor lysis syndrome
• chronic pain control
• central venous catheter occlusion clearance
• prevention and treatment of invasive fungal infection
• Graft-versus-Host Disease treatment post bone marrow transplantation
• supportive care of myelosupression using long acting hematopoietic growth factors

On the horizon, we are beginning new treatment studies for refractory and/or relapsed leukemiaís and solid tumors, long-acting anti-emetic supportive care, and additional prophylactic anti-fungal care. In our continuing efforts to provide state-of-the-art treatment and supportive care options in the fight against childhood cancers, we also work with the Pediatric Cancer Research Foundation Consortium.

For more information about current and future studies, contact Laura Gates, RN at (714) 516-4203.